Switch to:
Synageva BioPharma Corp (NAS:GEVA)
Construction In Progress
$0.00 Mil (As of Mar. 2015)

Synageva BioPharma Corp's annual construction in progress increased from Dec. 2012 ($0.00 Mil) to Dec. 2013 ($1.71 Mil) but then declined from Dec. 2013 ($1.71 Mil) to Dec. 2014 ($0.00 Mil).


It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Synageva BioPharma Corp Annual Data


Synageva BioPharma Corp Quarterly Data

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)